Lipoprotein(a) is a Determinant of Residual Cardiovascular Risk in the Setting of Optimal LDL-C in Statin-Treated Patients With Atherosclerotic Cardiovascular Disease

被引：0
|
作者：
Ruotolo, Giacomo
Lincoff, Michael A.
Menon, Venu
McErlean, Ellen
Wolski, Kathy
Haas, Joseph V.
Weerakkody, Govinda
Riesmeyer, Jeffrey S.
Nissen, Steven E.
Nicholls, Stephen J.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Lipoproteins; Apolipoproteins; Cardiovascular disease; Atherosclerosis; CETP inhibitors;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17400
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    Wong, Nathan D.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (03)
  • [2] Diabetes-Associated Residual Risk in Statin-Treated Patients with Atherosclerotic Cardiovascular Disease
    Wong, Nathan D.
    Zhao, Yanglu
    Xiang, Pin
    Antonio, J.
    Lopez, G.
    [J]. DIABETES, 2019, 68
  • [3] LDL-C TREATMENT GAPS IN STATIN-TREATED PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK IN EUROPE
    Gitt, A. K.
    Ambegaonkar, B.
    Brudi, P.
    Lautsch, D.
    [J]. ATHEROSCLEROSIS, 2014, 235 (02) : E106 - E106
  • [4] ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients
    Liem, A. H.
    De Woestijne, A. P. van
    van Lennep, H. W. O. Roeters
    Zwinderman, A. H.
    van der Steeg, W. A.
    Jukema, J. W.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 359 - 364
  • [5] Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
    Sirimarco, G.
    Labreuche, J.
    Bruckert, E.
    Goldstein, L. B.
    Fox, K. M.
    Rothwell, P. M.
    Amarenco, P.
    [J]. CEREBROVASCULAR DISEASES, 2014, 37 : 90 - 90
  • [6] Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
    Sirimarco, Gaia
    Labreuche, Julien
    Bruckert, Eric
    Goldstein, Larry B.
    Fox, Kim M.
    Rothwell, Peter M.
    Amarenco, Pierre
    [J]. STROKE, 2014, 45 (05) : 1429 - 1436
  • [7] Lipoprotein(a)-Associated Residual Atherosclerotic Cardiovascular Disease Risk in Patients with Cardiovascular Disease on Statin Therapy by Diabetes Status
    Zhao, Yanglu
    Sung, Jennifer C.
    Browne, Auris
    Wong, Nathan D.
    [J]. DIABETES, 2020, 69
  • [8] Residual atherosclerotic cardiovascular disease risk in statin-treated adults: the multi-ethnic study of atherosclerosis
    Wong, N. D.
    Zhao, Y.
    Quek, R. G. W.
    Blumenthal, R. S.
    Budoff, M. J.
    Cushman, M.
    Garg, P.
    Sandfort, V.
    Tsai, M.
    Lopez, J. A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1014 - 1014
  • [9] Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis
    Wong, Nathan D.
    Zhao, Yanglu
    Quek, Ruben G. W.
    Blumenthal, Roger S.
    Budoff, Matthew J.
    Cushman, Mary
    Garg, Parveen
    Sandfort, Veit
    Tsai, Michael
    Lopez, J. Antonio G.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (05) : 1223 - 1233
  • [10] STATIN TREATED PATIENTS AT VERY HIGH CARDIOVASCULAR RISK IN EUROPE: ARE THE MAJORITY CLOSE TO LDL-C
    Lautsch, D.
    Gitt, A. K.
    Brudi, P.
    Vanneste, B.
    Ambegaonkar, B.
    [J]. ATHEROSCLEROSIS, 2014, 235 (02) : E35 - E35
12345